As National Women’s Health Week approaches, new global data highlighting projected rises in breast and ovarian cancer through ...

Drug companies and specialty distributors navigate challenges like profitability, supply chain volatility, regulatory complexities, and market pressures to build successful partnerships, said Natalie ...

Clinical trials for idiopathic pulmonary fibrosis could benefit from improved patient engagement to include diverse ...

FDA approves the first treatment for KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC), offering new hope for ...

New research links arthritis to an increased risk of prostate cancer, highlighting the need for further studies on prevention ...

Measles cases surge in the US as vaccination rates decline, raising concerns about outbreaks and public health under Robert F ...

Antoine Keller, MD, argued the value of grounding health care policy in equity as clinicians prepare for a changing health ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Learn about how Allegheny Health Network's "Food as Medicine" initiative tackles food insecurity and enhances health through ...

Panelists discuss how neurofibromatosis type 1 (NF1) is typically diagnosed in early childhood using National Institutes of ...